Collectively, pseudotime analysis indicated that estrogen and progesterone drived the occurrence and progression of uterine leiomyoma and ERK1/ERK2 signaling pathway might participate in the processes. The gene discussed is MAPK1; the disease is uterine corpus leiomyoma.